Fanny Astruc-Diaz Selected Research

N'- ((3Z)- 1- (1- hexyl)- 2- oxo- 1,2- dihydro- 3H- indol- 3- ylidene)benzohydrazide

7/2010

Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fanny Astruc-Diaz Research Topics

Disease

3	Neuralgia (Stump Neuralgia) 07/2010 - 08/2008
2	Ischemia 04/2021 - 03/2015
1	Ischemic Stroke 04/2021
1	Stroke (Strokes) 04/2021
1	Reperfusion Injury 03/2015
1	Hyperalgesia 07/2010

Drug/Important Bio-Agent (IBA)

2	AMPA Receptors (AMPA Receptor)IBA 04/2021 - 03/2015
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2010 - 08/2008
1	FSC 231IBA 04/2021
1	CalciumIBA 04/2021
1	AcidsIBA 03/2015
1	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2015
1	CannabinoidsIBA 07/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2010
1	N'- ((3Z)- 1- (1- hexyl)- 2- oxo- 1,2- dihydro- 3H- indol- 3- ylidene)benzohydrazideIBA 07/2010
1	LigandsIBA 07/2010
1	CarbonIBA 10/2009
1	IsatinIBA 08/2008

Therapy/Procedure

1	Therapeutics 04/2021
1	Ligation 07/2010